Evidence map›Paper›PMID 20375132›Full record

ArticleBrain : a journal of neurology2010

A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry.

Soufiane El Hallani, Blandine Boisselier, Florent Peglion, Audrey Rousseau, Carole Colin, Ahmed Idbaih, Yannick Marie, Karima Mokhtari, Jean-Léon Thomas, Anne Eichmann and 3 more

Abstract readComparative Study
In one paragraph

Article in Brain : a journal of neurology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 205 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
205citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

205 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Von Hippel-Lindau/Hypoxia Inducible Factor Axis in Glioblastoma.International journal of molecular sciences · 2025
    Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Glioblastoma Therapy: Past, Present and Future.International journal of molecular sciences · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Article

145 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Soufiane El HallaniUMR975, Hôpital de la Salpêtrière, Université Pierre et Marie Curie, Paris, France. soufiane.elhallani@yahoo.ca
Blandine Boisselier
Florent Peglion
Audrey Rousseau
Carole Colin
Ahmed Idbaih
Yannick Marie
Karima Mokhtari
Jean-Léon Thomas
Anne Eichmann
Jean-Yves Delattre
Andrew J Maniotis
Marc Sanson

Funding

Novel approaches to manipulate sprouting angiogenesisR01EY025979 · NEI · YALE UNIVERSITY · PI EICHMANN, ANNE CHRISTINE · 2015 to 2019
$1.9M
NEI NIH HHS R01 EY025979
6 · The paper itself

Abstract

Glioblastoma is one of the most angiogenic human tumours and endothelial proliferation is a hallmark of the disease. A better understanding of glioblastoma vasculature is needed to optimize anti-angiogenic therapy that has shown a high but transient efficacy. We analysed human glioblastoma tissues and found non-endothelial cell-lined blood vessels that were formed by tumour cells (vasculogenic mimicry of the tubular type). We hypothesized that CD133+ glioblastoma cells presenting stem-cell properties may express pro-vascular molecules allowing them to form blood vessels de novo. We demonstrated in vitro that glioblastoma stem-like cells were capable of vasculogenesis and endothelium-associated genes expression. Moreover, a fraction of these glioblastoma stem-like cells could transdifferentiate into vascular smooth muscle-like cells. We describe here a new mechanism of alternative glioblastoma vascularization and open a new perspective for the antivascular treatment strategy.

Indexed as

AdultAgedAged, 80 and overAnimalsBlood VesselsCell Line, TransformedCells, CulturedEndothelial CellsFemaleGlioblastomaHumansMaleMiddle AgedMolecular MimicryNeoplastic Stem CellsNeovascularization, Pathologic

Identifiers

PMID20375132
PMCPMC4861203

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.